• Corpus ID: 18818517

Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions.

@article{Hunsberger2013MoodSM,
  title={Mood stabilizer-regulated miRNAs in neuropsychiatric and neurodegenerative diseases: identifying associations and functions.},
  author={Joshua G Hunsberger and Emily Bame Fessler and Fairouz L Chibane and Yan Leng and Dragan Maric and Abdel G. Elkahloun and De Maw Chuang},
  journal={American journal of translational research},
  year={2013},
  volume={5 4},
  pages={
          450-64
        }
}
Identifying mechanisms to enhance neuroprotection holds tremendous promise in developing new treatments for neuropsychiatric and neurodegenerative diseases. We sought to determine the potential role for microRNAs (miRNAs) in neuroprotection following neuronal death. A neuronal culture system of rat cerebellar granule cells was used to examine miRNA expression changes following glutamate-induced excitotoxicity and neuroprotective treatments. Combination treatment with the mood stabilizers… 
MicroRNAs and psychiatric disorders: From aetiology to treatment.
TLDR
The mechanisms that regulate microRNA biogenesis are described and the potential to consider microRNAs as putative target for pharmacological intervention, using common psychotropic drugs or more specific tools, with the aim to normalize functions that are disrupted in different psychiatric conditions is discussed.
Dysregulation of miR-34a Links Neuronal Development to Genetic Risk Factors for Bipolar Disorder
TLDR
It is proposed that miR-34a serves as a critical link between multiple etiological factors for BD and its pathogenesis through the regulation of a molecular network essential for neuronal development and synaptogenesis.
Lithium protects against paraquat neurotoxicity by NRF2 activation and miR-34a inhibition in SH-SY5Y cells
TLDR
Two novel mechanisms of lithium neuroprotection are revealed, namely NRF2 activation and miR-34a suppression and lithium significantly decreased both basal and PQ-induced expression of miR -34a.
Lithium/Valproic Acid Combination and l-Glutamate Induce Similar Pattern of Changes in the Expression of miR-30a-5p in SH-SY5Y Neuroblastoma Cells
TLDR
Investigating whether exposure to Li and VPA may influence miR-30a-5p expression in an in vitro model of neurodegeneration generated by the exposure of a human neuroblastoma cell line to neurotoxic concentration of l-glutamate showed results that indicate that miRNA changes are present in in vitro models of neuro degeneration, although the significance of these changes warrants further investigation.
Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future
TLDR
The current knowledge on miRNA alteration/dysregulation in neuropsychiatric disorders, with a special emphasis on schizophrenia (SCZ), bipolar disorder (BD), and major depressive disorder (MDD) is summarized.
Lithium-induced neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein deubiquitination by GSK3β inhibition-independent pathways
TLDR
This study for the first time provides efficacy data for lithium in the postacute ischemic phase, reporting a novel mechanism of action, i.e. increased miR-124 expression facilitating REST degradation by which lithium promotes postischemic neuroplasticity and angiogenesis.
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings
TLDR
This study suggests that miR-4286 could be a biomarker of suicide but further studies are warranted to investigate its targeted genes and how these could be involved in the neurobiology of suicide.
MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: Current progress in genetic association studies, expression profiling, and translational research
  • Yubin Hu, E. Ehli, D. Boomsma
  • Biology, Medicine
    Autism research : official journal of the International Society for Autism Research
  • 2017
TLDR
The role of miRNAs in autism spectrum disorder (ASD) is focused on and recent findings about ASD‐associated genetic variants in miRNA genes, in mi RNA biogenesis genes, and miRNA targets are summarized.
MicroRNAs in Neuronal Communication
TLDR
In this review, the hot topics on miRNA gene-regulatory activities in the broad field of neuronal communication-related processes are examined and newly described and under-investigation mechanisms involving the intercellular transfer of miRNAs, aided by exosomes and gap junctions are discussed.
Discovering novel microRNAs and age-related nonlinear changes in rat brains using deep sequencing
TLDR
Unexpectedly, miRNA expression did not decline progressively with advancing age; moreover, genes targeted by age-associated miRNAs were predicted to be involved in biological processes linked to aging and neurodegenerative diseases.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 76 REFERENCES
Evidence for Selective microRNAs and Their Effectors as Common Long-Term Targets for the Actions of Mood Stabilizers
TLDR
These findings are the first to demonstrate that miRNAs and their predicted effectors are targets for the action of psychotherapeutic drugs.
Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia.
TLDR
Data from a rat model of middle cerebral artery occlusion to induce cerebral ischemia support common disease mechanisms that may be under miRNA control and provide exciting directions for further investigations aimed at elucidating the miRNA mechanisms and targets that may yield new therapies for neurological disorders.
MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function.
TLDR
It is proposed that early deregulation of miR-34b/c in PD triggers downstream transcriptome alterations underlying mitochondrial dysfunction and oxidative stress, which ultimately compromise cell viability.
Convergence of miRNA Expression Profiling, α-Synuclein Interacton and GWAS in Parkinson's Disease
TLDR
Findings suggest that several miRNAs may act as regulators of both known and novel biological processes leading to idiopathic PD, as well as novel pathways previously linked to PD.
Gain of survival signaling by down-regulation of three key miRNAs in brain of calorie-restricted mice
TLDR
Down-regulation of miR-34a, -30e, and -181a permits their shared target gene expression (Bcl-2) to remain at a high level without post-transcriptional repression, accompanied by concomitant low levels of Bax expression and Caspase cleaving; this chain event may be a part of the underlying mechanism contributing to the gain in neuronal survival in long-lived CR-fed mice.
Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease.
TLDR
This is the first study suggesting that plasma miRs might be used as biomarkers for HD, and it is found that miR-34b is significantly elevated in response to mHTt-Exon-1, and its blockade alters the toxicity of mHTT-ExOn-1 in vitro.
Dysregulation of miRNA 181b in the temporal cortex in schizophrenia.
Analysis of global microRNA (miRNA) expression in postmortem cortical grey matter from the superior temporal gyrus, revealed significant up-regulation of miR-181b expression in schizophrenia. This
MicroRNA Expression Is Down-Regulated and Reorganized in Prefrontal Cortex of Depressed Suicide Subjects
TLDR
Overall miRNA expression was significantly and globally down-regulated in prefrontal cortex of depressed suicide subjects, and a set of 29 miRNAs showed a high degree of co-regulation across individuals in the depressed suicide group.
The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNS
TLDR
These novel findings represent the first report of medication‐induced increases in CNS bcl‐2 levels and may have implications not only for mood disorders, but also for long‐term treatment of various neurodegenerative disorders.
Endogenous α-Synuclein Is Induced by Valproic Acid through Histone Deacetylase Inhibition and Participates in Neuroprotection against Glutamate-Induced Excitotoxicity
TLDR
It is demonstrated for the first time that VPA induces α-syn in neurons through inhibition of HDAC and that thisα-syn induction is critically involved in neuroprotection against glutamate excitotoxicity.
...
1
2
3
4
5
...